Lupus hair loss: understanding shedding and scarring scalp changes

Lupus can involve more than one type of hair loss

Lupus is an autoimmune condition in which immune activity contributes to inflammation affecting the body’s own tissues. Systemic lupus can involve several organs, whereas some forms remain confined to the skin. Having a lupus skin lesion does not, by itself, establish that the kidneys or other internal organs are affected.

For hair, a useful distinction is between loss without scarring destruction and disease that causes lasting damage to follicles. Concha and Werth’s review (2018) also describes hair loss occurring in people with lupus that is not specific to the condition. These processes can overlap, explaining why different areas of one person’s scalp may behave differently.

Reduced volume, fragile strands and a bare patch are observations rather than diagnoses. They cannot identify the underlying condition or reliably predict recovery on their own. The term alopecia describes hair loss; it does not provide enough information to select an appropriate treatment.

Widespread shedding does not always indicate an active flare

Non-scarring hair loss associated with lupus can leave the hair less full, sometimes with fragile strands around the forehead. It may accompany disease activity and improve with treatment of that disease. However, a scalp that looks normal does not establish this diagnosis: some changes only become apparent during a dermatological examination.

Telogen effluvium is another possibility. This involves altered hair renewal, with delayed shedding after a flare, an illness involving fever or another event that places strain on the body. That delay helps explain why hair may continue falling out after other symptoms have already settled.

Depending on your circumstances, the clinician also considers factors such as iron deficiency, thyroid disease, restricted food intake or medication effects. Androgenetic alopecia, which involves progressive thinning, can coexist with lupus. Identifying these contributions helps avoid attributing every hair change to one cause or trying several unrelated treatments without a clear reason.

If shedding follows a prescription change, note the dates and contact the prescriber. The sequence alone does not prove that the medicine caused it, because increased disease activity may have prompted that change. Do not stop lupus medication yourself: a clinical review can weigh its benefits and risks and discuss alternatives where appropriate.

Inflamed patches need a dermatological assessment

Discoid lupus is a form of cutaneous lupus that can involve the scalp. It can produce red or purplish patches, adherent scale, changes in pigmentation and reduced hair coverage. Discomfort, itching or burning may occur, although some lesions cause few symptoms and can develop without drawing much attention.

An early discoid lupus lesion is not necessarily completely scarred. Treatment then aims to limit damage before it becomes irreversible. Once the structures essential for follicular renewal have been lost and replaced with fibrous tissue, the destroyed follicles can no longer produce hair.

This form of scarring alopecia may leave skin that looks smoother, thinner or different in colour. Other disorders can produce similar appearances, so matching your scalp to photographs online is insufficient. Alopecia areata, infection or another inflammatory disorder may require a different approach.

Contact your GP or dermatologist if a bare area spreads, new patches develop or the skin becomes painful, scaly or crusted. A lack of discomfort is not a reason to delay assessment of a changing lesion. If you already receive lupus care, report the change to the team familiar with your condition and current treatment.

What the assessment needs to establish

The consultation starts with the course of the hair loss and your lupus history. Explain which areas changed first, recent flares, medicines you take and products applied to the scalp. Older photographs may help reconstruct the course, but they cannot reveal inflammation beneath the surface or show the condition of every follicle.

A dermatologist examines the hair shafts, follicular openings and surrounding skin. Trichoscopy, which provides a magnified view of the scalp, supplies additional detail. When a specific lupus lesion or scarring disease is suspected, a biopsy may be recommended to examine a small skin sample; the site is selected according to the clinical findings.

Blood tests address questions raised by the examination and medical history. When systemic lupus is suspected, investigations may look for autoantibodies and assess possible involvement beyond the skin. NIAMS explains that antinuclear antibodies can also be positive in other circumstances, including in healthy people: one positive result cannot confirm lupus.

Equally, a blood test cannot replace assessment of an individual scalp lesion. Depending on the circumstances, the clinician may investigate accompanying anaemia, nutritional deficiency or thyroid dysfunction, rather than ordering the same panel for everyone. The aim is a sufficiently clear explanation to guide care, with reassessment if subsequent changes do not fit the expected course.

Control inflammation before focusing on hair growth

Treatment choices depend on the form of lupus, its activity and any other organs involved. A dermatologist may work alongside your GP, rheumatologist or another specialist. A product marketed for hair cannot replace that care when the disease requires treatment affecting the body more broadly.

For some skin lesions, clinicians use topical corticosteroids or injections into affected areas. Hydroxychloroquine may form part of lupus treatment, while other medicines affecting immune activity are considered according to individual needs. These treatments require prescribing and appropriate monitoring, including eye monitoring for hydroxychloroquine, and cannot be chosen from a photograph or someone else’s online experience.

Desai and Miteva (2021) highlight the limitations of evidence specifically addressing hair regrowth in lupus. An improvement in overall disease activity does not provide a personal percentage chance of recovering hair. Small series and individual case reports cannot establish that the same combination of medicines will suit everyone affected.

Topical minoxidil is sometimes considered as an additional treatment, particularly when another form of alopecia coexists. It cannot control lupus inflammation on its own or recreate follicles lost to scarring. Vitamin injections, mesotherapy and products described as regenerative lack robust evidence to support their routine use as a response to lupus-related hair loss.

Regrowth and disease control are separate outcomes

Where follicles remain functional, hair recovery may follow treatment of the underlying process. This takes time: the hair cycle and the length needed to restore visible volume both create a delay. There is no single timetable that can promise a return to your previous hair coverage.

Established scarring creates a different limitation. Treatment progress is then assessed through outcomes such as lesions no longer spreading, reduced inflammatory signs and retention of remaining hair. A lack of regrowth in the centre of a scarred patch does not necessarily mean that treatment is serving no purpose.

Follow-up helps distinguish continuing hair loss, slow recovery and an additional cause that was not previously apparent. Occasional photographs taken under comparable conditions can supplement the examination if you find them useful. Checking in the mirror every day cannot reliably assess lupus activity and may become emotionally tiring.

If shedding increases, a new lesion appears or treatment becomes difficult to tolerate, contact your clinical team again. A change of approach may be needed, but it should follow a fresh assessment. The disappearance of redness is also insufficient to establish lasting inactivity in a condition that can fluctuate through flares and quieter periods.

Protect your scalp without adding unnecessary products

Ultraviolet protection is an important part of lupus care because sunlight can trigger or worsen skin manifestations. Discuss a covering hat, shade and suitable sunscreen for exposed areas with your healthcare team. A wider parting or a thinning patch leaves more skin exposed than it was when hair coverage was greater.

For everyday care, favour handling that avoids tension and irritation: gentle detangling, loose hairstyles and limiting processes that aggravate sensitive skin. If lesions are active, ask for advice before colouring, chemical straightening or applying a new product. A well-tolerated shampoo maintains the hair and scalp; it does not suppress the inflammation responsible for lupus.

A varied diet helps meet ordinary nutritional needs, but a hair supplement does not automatically correct shedding. NIAMS advises that some supplements and non-prescription products can interfere with medicines. Tell your doctor or pharmacist what you take, and base any nutritional correction on an identified need rather than a promise on the packaging.

Appearance and emotional wellbeing belong in the discussion

Temporary shedding can be distressing even when the outlook is favourable. Lasting hair loss may affect social habits, confidence or how you feel when looking in the mirror. You can raise these concerns during an appointment before they become overwhelming; their impact on daily life is relevant to your care.

A wig, hairpiece, headscarf or different hairstyle may suit your preferences. Comfort and scalp condition matter, particularly if attachments or rubbing irritate an existing lesion. There is no expectation that you must conceal hair loss, or make a permanent decision while its course remains uncertain.

Psychological support may help when worry, low mood or isolation become difficult to manage. NIAMS includes support from mental health professionals within lupus care, and your GP can help you discuss suitable options. This support accompanies dermatological and lupus care; it does not imply that the hair loss is imagined or simply caused by stress.

A transplant after lupus requires a particularly careful decision

A transplant moves follicles into an area lacking hair; it cannot cure lupus. It is not the response to widespread shedding that may recover, and it should not be performed in an area affected by active inflammatory disease. Our guide to understanding hair transplantation explains the general stages, alongside which a specific dermatological assessment is needed here.

Singh and Muthuvel’s review (2021) describes challenges particular to inflammatory scarring alopecia: activity can be subtle, the condition of recipient skin varies and disease may recur. Available evidence cannot establish that grafts will survive long term in lupus. A symptom-free interval, even a lengthy one, is insufficient on its own to establish that surgery is appropriate.

In carefully selected cases, specialists may discuss reconstruction after assessing disease stability, donor hair, current treatment and risks. They may also conclude that surgery remains unsuitable. No technique, including FUE, removes those medical limitations or eliminates the possibility of scars resulting from the procedure.

Before discussing a hair transplant in Istanbul with Body Expert, your diagnosis and existing follow-up need to be clarified. Gather relevant clinical reports so that your circumstances can be considered with their constraints. Continuing medical care or choosing a non-surgical cosmetic option may be the appropriate decision, without promising restoration that the scalp cannot support.

Sources

Concha, J. S. S., & Werth, V. P. (2018). Alopecias in lupus erythematosus. Lupus Science & Medicine, 5(1), e000291. Full text.

Desai, K., & Miteva, M. (2021). Recent insight on the management of lupus erythematosus alopecia. Clinical, Cosmetic and Investigational Dermatology, 14, 333–347. Full text.

Singh, S., & Muthuvel, K. (2021). Role of hair transplantation in scarring alopecia: To do or not to do. Indian Journal of Plastic Surgery, 54(4), 501–506. Full text.

National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2022, October). Systemic lupus erythematosus: Diagnosis, treatment, and steps to take. Public health information.

National Health Service. (2023, July 19). Lupus. Public health information.